← Every company
Anavex Life Sciences Corp SEC Filings
What Anavex Life Sciences Corp has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
AVXL overview →Filings on file
79
since Dec 14, 2016
Warning signs
4
latest Aug 10, 2026
Last results
Aug 25, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Sep 28, 2026 | Change in controlShareholder vote 8-K | Read ↗ |
| Aug 28, 2026 | Quarterly report 10-Q | Read ↗ |
| Aug 28, 2026 | Quarterly report 10-Q | Read ↗ |
| Aug 28, 2026 | Quarterly report 10-Q/A | Read ↗ |
| Aug 28, 2026 | Annual report 10-K/A | Read ↗ |
| Aug 25, 2026 | Results announced 8-K | Read ↗ |
| Aug 10, 2026 | Late filing notice NT 10-Q | Read ↗ |
| Jul 30, 2026 | Results announced 8-K | Read ↗ |
| May 22, 2026 | Delisting notice or listing transfer 8-K | Read ↗ |
| May 15, 2026 | Executive or director change 8-K | Read ↗ |
| May 11, 2026 | Late filing notice NT 10-Q | Read ↗ |
| May 6, 2026 | Executive or director change 8-K | Read ↗ |
| Feb 25, 2026 | Executive or director change 8-K | Read ↗ |
| Feb 9, 2026 | Quarterly report 10-Q | Read ↗ |
| Feb 9, 2026 | Results announced 8-K | Read ↗ |
| Nov 25, 2025 | Annual report 10-K | Read ↗ |
| Nov 25, 2025 | Results announced 8-K | Read ↗ |
| Aug 12, 2025 | Quarterly report 10-Q | Read ↗ |
| Jul 28, 2025 | Material agreement 8-K | Read ↗ |
| Jul 3, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 13, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 13, 2025 | Quarterly report 10-Q | Read ↗ |
| Feb 12, 2025 | Quarterly report 10-Q | Read ↗ |
| Dec 23, 2024 | Annual report 10-K | Read ↗ |
| Aug 6, 2024 | Quarterly report 10-Q | Read ↗ |
| Jul 30, 2024 | Material agreement 8-K | Read ↗ |
| Jun 21, 2024 | Shareholder vote 8-K | Read ↗ |
| May 9, 2024 | Quarterly report 10-Q | Read ↗ |
| May 9, 2024 | Results announced 8-K | Read ↗ |
| Feb 7, 2024 | Quarterly report 10-Q | Read ↗ |
| Nov 27, 2023 | Annual report 10-K | Read ↗ |
| Aug 8, 2023 | Quarterly report 10-Q | Read ↗ |
| May 24, 2023 | Shareholder vote 8-K | Read ↗ |
| May 9, 2023 | Quarterly report 10-Q | Read ↗ |
| Feb 7, 2023 | Quarterly report 10-Q | Read ↗ |
| Jan 27, 2023 | Annual report 10-K/A | Read ↗ |
| Nov 28, 2022 | Annual report 10-K | Read ↗ |
| Aug 9, 2022 | Quarterly report 10-Q | Read ↗ |
| May 27, 2022 | Shareholder vote 8-K | Read ↗ |
| May 10, 2022 | Quarterly report 10-Q | Read ↗ |
| Apr 8, 2022 | Executive or director change 8-K | Read ↗ |
| Mar 4, 2022 | Auditor changeExecutive or director change 8-K | Read ↗ |
| Feb 9, 2022 | Quarterly report 10-Q | Read ↗ |
| Nov 24, 2021 | Annual report 10-K | Read ↗ |
| Aug 12, 2021 | Quarterly report 10-Q | Read ↗ |
| Jun 24, 2021 | Material agreement 8-K | Read ↗ |
| May 28, 2021 | Shareholder vote 8-K | Read ↗ |
| May 13, 2021 | Quarterly report 10-Q | Read ↗ |
| Feb 16, 2021 | Quarterly report 10-Q | Read ↗ |
| Dec 28, 2020 | Results announced 8-K | Read ↗ |
| Dec 28, 2020 | Annual report 10-K | Read ↗ |
| Aug 6, 2020 | Quarterly report 10-Q | Read ↗ |
| Jul 2, 2020 | Material agreement 8-K | Read ↗ |
| May 7, 2020 | Quarterly report 10-Q | Read ↗ |
| May 1, 2020 | Material agreement 8-K | Read ↗ |
| Apr 8, 2020 | Shareholder vote 8-K | Read ↗ |
| Feb 6, 2020 | Quarterly report 10-Q | Read ↗ |
| Dec 16, 2019 | Annual report 10-K | Read ↗ |
| Aug 7, 2019 | Quarterly report 10-Q | Read ↗ |
| Jun 12, 2019 | Material agreement 8-K | Read ↗ |
| May 9, 2019 | Quarterly report 10-Q | Read ↗ |
| Apr 8, 2019 | Shareholder vote 8-K | Read ↗ |
| Feb 7, 2019 | Quarterly report 10-Q | Read ↗ |
| Jan 25, 2019 | Annual report 10-K/A | Read ↗ |
| Dec 12, 2018 | Annual report 10-K | Read ↗ |
| Aug 9, 2018 | Quarterly report 10-Q | Read ↗ |
| Jul 6, 2018 | Material agreement 8-K | Read ↗ |
| May 10, 2018 | Quarterly report 10-Q | Read ↗ |
| Apr 20, 2018 | Shareholder vote 8-K | Read ↗ |
| Mar 8, 2018 | Executive or director change 8-K | Read ↗ |
| Feb 7, 2018 | Quarterly report 10-Q | Read ↗ |
| Dec 11, 2017 | Annual report 10-K | Read ↗ |
| Oct 6, 2017 | Executive or director change 8-K | Read ↗ |
| Aug 7, 2017 | Quarterly report 10-Q | Read ↗ |
| May 10, 2017 | Quarterly report 10-Q | Read ↗ |
| Apr 21, 2017 | Shareholder vote 8-K | Read ↗ |
| Feb 13, 2017 | Executive or director change 8-K | Read ↗ |
| Feb 7, 2017 | Quarterly report 10-Q | Read ↗ |
| Dec 14, 2016 | Annual report 10-K | Read ↗ |
Source: Anavex Life Sciences Corp's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on AVXL
Company overviewEverything on AVXL in one place, with the price.Insider tradingWhat AVXL's own officers and directors buy and sell.Who owns itEvery manager reporting a position in AVXL.Funds holding itWhich funds and ETFs hold AVXL, and how big a bet.LobbyingWhat AVXL spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on AVXL's account, and who they worked for.PatentsWhat AVXL is filing at the patent office.